| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, CD | 120 | 2024 | 4026 | 5.420 |
Why?
|
| CD8-Positive T-Lymphocytes | 76 | 2024 | 4479 | 4.920 |
Why?
|
| Lymphocyte Activation | 107 | 2023 | 5524 | 3.850 |
Why?
|
| T-Lymphocytes | 92 | 2024 | 10183 | 3.820 |
Why?
|
| Membrane Glycoproteins | 100 | 2018 | 3771 | 3.810 |
Why?
|
| T-Lymphocytes, Regulatory | 46 | 2024 | 2988 | 3.700 |
Why?
|
| Antigens, Differentiation | 51 | 2012 | 927 | 3.440 |
Why?
|
| Autoimmunity | 27 | 2023 | 1350 | 3.200 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 20 | 2019 | 985 | 3.180 |
Why?
|
| Immunotherapy | 30 | 2024 | 4446 | 2.850 |
Why?
|
| Autoimmune Diseases | 28 | 2024 | 2134 | 2.680 |
Why?
|
| Immune Tolerance | 39 | 2023 | 2259 | 2.650 |
Why?
|
| Germinal Center | 17 | 2022 | 377 | 2.360 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 18 | 2023 | 834 | 2.250 |
Why?
|
| Immunoconjugates | 33 | 2003 | 901 | 2.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 4 | 2023 | 51 | 1.910 |
Why?
|
| Lymphocytic Choriomeningitis | 15 | 2022 | 132 | 1.830 |
Why?
|
| CD4-Positive T-Lymphocytes | 60 | 2023 | 4386 | 1.760 |
Why?
|
| Mice | 316 | 2024 | 81201 | 1.740 |
Why?
|
| Apoptosis Regulatory Proteins | 24 | 2013 | 1157 | 1.720 |
Why?
|
| B-Lymphocytes | 30 | 2023 | 4666 | 1.710 |
Why?
|
| Mice, Knockout | 135 | 2023 | 14561 | 1.660 |
Why?
|
| Lymphocytic choriomeningitis virus | 14 | 2021 | 168 | 1.650 |
Why?
|
| Animals | 364 | 2024 | 168768 | 1.610 |
Why?
|
| Peptides | 35 | 2022 | 4410 | 1.520 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 19 | 2012 | 906 | 1.500 |
Why?
|
| Mice, Inbred C57BL | 130 | 2021 | 21833 | 1.390 |
Why?
|
| Neoplasms | 27 | 2023 | 21696 | 1.370 |
Why?
|
| Immune System Diseases | 3 | 2023 | 261 | 1.340 |
Why?
|
| Receptors, Antigen, T-Cell | 24 | 2023 | 2540 | 1.320 |
Why?
|
| Mice, Inbred BALB C | 98 | 2021 | 6386 | 1.250 |
Why?
|
| Antigen-Presenting Cells | 24 | 2014 | 973 | 1.240 |
Why?
|
| Th2 Cells | 26 | 2022 | 1061 | 1.210 |
Why?
|
| Immunologic Memory | 16 | 2021 | 1348 | 1.190 |
Why?
|
| Signal Transduction | 58 | 2023 | 23404 | 1.180 |
Why?
|
| Antigens, Surface | 19 | 2011 | 1663 | 1.180 |
Why?
|
| Receptors, Immunologic | 10 | 2023 | 1423 | 1.100 |
Why?
|
| Mice, Transgenic | 65 | 2019 | 9735 | 1.100 |
Why?
|
| Cell Differentiation | 48 | 2022 | 11486 | 1.090 |
Why?
|
| Melanoma | 12 | 2023 | 5511 | 1.090 |
Why?
|
| Antibody Formation | 13 | 2020 | 1402 | 1.070 |
Why?
|
| T-Lymphocyte Subsets | 30 | 2022 | 1837 | 1.030 |
Why?
|
| Antibodies, Monoclonal | 36 | 2021 | 9274 | 1.020 |
Why?
|
| Tumor Microenvironment | 20 | 2023 | 3590 | 0.960 |
Why?
|
| Self Tolerance | 5 | 2016 | 125 | 0.940 |
Why?
|
| Dendritic Cells | 22 | 2018 | 2725 | 0.930 |
Why?
|
| Immunity | 9 | 2022 | 1014 | 0.910 |
Why?
|
| Cytotoxicity, Immunologic | 9 | 2019 | 1369 | 0.900 |
Why?
|
| Tumor Escape | 6 | 2017 | 350 | 0.900 |
Why?
|
| Leishmaniasis, Cutaneous | 8 | 2014 | 124 | 0.880 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 10 | 2021 | 1038 | 0.850 |
Why?
|
| Lymph Nodes | 16 | 2023 | 3476 | 0.790 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2020 | 90 | 0.720 |
Why?
|
| Autoantibodies | 9 | 2020 | 2036 | 0.710 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2020 | 248 | 0.710 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2019 | 20 | 0.710 |
Why?
|
| Immunity, Innate | 12 | 2023 | 2962 | 0.700 |
Why?
|
| Th1 Cells | 13 | 2006 | 1057 | 0.670 |
Why?
|
| Immunomodulation | 6 | 2019 | 541 | 0.650 |
Why?
|
| Arenaviridae Infections | 5 | 2017 | 51 | 0.650 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2023 | 3338 | 0.640 |
Why?
|
| Immunity, Humoral | 6 | 2019 | 598 | 0.630 |
Why?
|
| Forkhead Transcription Factors | 10 | 2023 | 1613 | 0.630 |
Why?
|
| Mice, Inbred NOD | 14 | 2023 | 1879 | 0.620 |
Why?
|
| T-Lymphocytes, Cytotoxic | 13 | 2011 | 1821 | 0.610 |
Why?
|
| Interleukin-4 | 15 | 2012 | 1147 | 0.610 |
Why?
|
| Listeria monocytogenes | 2 | 2021 | 250 | 0.600 |
Why?
|
| Cytokines | 43 | 2021 | 7323 | 0.600 |
Why?
|
| Down-Regulation | 15 | 2023 | 3001 | 0.600 |
Why?
|
| Communicable Diseases | 2 | 2021 | 880 | 0.590 |
Why?
|
| Blood Proteins | 6 | 2004 | 1124 | 0.590 |
Why?
|
| Melanoma, Experimental | 5 | 2023 | 561 | 0.590 |
Why?
|
| Antigen Presentation | 14 | 2023 | 1284 | 0.580 |
Why?
|
| Interleukin-2 | 16 | 2024 | 1904 | 0.570 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2016 | 246 | 0.570 |
Why?
|
| Lymphocytes | 8 | 2021 | 2617 | 0.540 |
Why?
|
| Ligands | 22 | 2023 | 3282 | 0.540 |
Why?
|
| Ovalbumin | 14 | 2022 | 719 | 0.530 |
Why?
|
| Adaptive Immunity | 3 | 2021 | 714 | 0.520 |
Why?
|
| Antibodies, Blocking | 14 | 2019 | 253 | 0.520 |
Why?
|
| Graft vs Host Disease | 13 | 2022 | 2958 | 0.510 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 1225 | 0.500 |
Why?
|
| Leishmania major | 5 | 2014 | 57 | 0.490 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1115 | 0.490 |
Why?
|
| Cell Communication | 7 | 2014 | 1621 | 0.480 |
Why?
|
| Models, Immunological | 7 | 2010 | 527 | 0.480 |
Why?
|
| Growth Inhibitors | 4 | 2011 | 385 | 0.470 |
Why?
|
| Antigens | 10 | 2015 | 1466 | 0.470 |
Why?
|
| Alternative Splicing | 3 | 2012 | 1117 | 0.470 |
Why?
|
| Immune System | 5 | 2023 | 806 | 0.460 |
Why?
|
| Retroviridae Infections | 5 | 2002 | 151 | 0.460 |
Why?
|
| Interleukin-6 | 4 | 2022 | 3203 | 0.450 |
Why?
|
| Liver Diseases | 1 | 2022 | 1253 | 0.450 |
Why?
|
| Tumor Cells, Cultured | 5 | 2020 | 6313 | 0.450 |
Why?
|
| Immunoglobulin Class Switching | 4 | 2014 | 291 | 0.450 |
Why?
|
| Cells, Cultured | 40 | 2019 | 19233 | 0.430 |
Why?
|
| Disease Models, Animal | 30 | 2023 | 18034 | 0.430 |
Why?
|
| Interferon-gamma | 22 | 2023 | 3207 | 0.430 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 328 | 0.430 |
Why?
|
| Interleukins | 7 | 2016 | 791 | 0.430 |
Why?
|
| Reoviridae | 14 | 1987 | 161 | 0.430 |
Why?
|
| Humans | 147 | 2024 | 744366 | 0.420 |
Why?
|
| Adoptive Transfer | 15 | 2016 | 844 | 0.420 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 5172 | 0.420 |
Why?
|
| Flow Cytometry | 27 | 2023 | 5974 | 0.410 |
Why?
|
| Killer Cells, Natural | 8 | 2022 | 2133 | 0.410 |
Why?
|
| Immunity, Mucosal | 3 | 2018 | 490 | 0.400 |
Why?
|
| Cell Line, Tumor | 19 | 2021 | 16690 | 0.400 |
Why?
|
| Spleen | 21 | 2018 | 2362 | 0.400 |
Why?
|
| Viral Envelope Proteins | 3 | 2020 | 636 | 0.390 |
Why?
|
| Gene Expression Regulation | 18 | 2019 | 12073 | 0.390 |
Why?
|
| Immunoassay | 1 | 2015 | 752 | 0.390 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 2542 | 0.380 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1271 | 0.380 |
Why?
|
| Graft Rejection | 16 | 2017 | 4397 | 0.380 |
Why?
|
| Lupus Erythematosus, Systemic | 8 | 2013 | 2104 | 0.380 |
Why?
|
| Bone Marrow Transplantation | 13 | 2019 | 2765 | 0.380 |
Why?
|
| Interleukin-10 | 12 | 2022 | 1200 | 0.380 |
Why?
|
| Bronchiolitis Obliterans | 3 | 2022 | 194 | 0.380 |
Why?
|
| Glomerulonephritis | 4 | 2011 | 372 | 0.380 |
Why?
|
| Myocarditis | 6 | 2021 | 771 | 0.370 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 2022 | 805 | 0.370 |
Why?
|
| Antigens, Neoplasm | 6 | 2023 | 1988 | 0.360 |
Why?
|
| Receptors, Tumor Necrosis Factor | 5 | 2009 | 595 | 0.360 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2016 | 3390 | 0.350 |
Why?
|
| Macrophages, Peritoneal | 3 | 2022 | 251 | 0.350 |
Why?
|
| Heart Transplantation | 15 | 2021 | 3112 | 0.340 |
Why?
|
| Clonal Deletion | 3 | 2019 | 79 | 0.340 |
Why?
|
| Carcinoma, Renal Cell | 5 | 2024 | 3143 | 0.330 |
Why?
|
| Listeriosis | 2 | 2021 | 149 | 0.330 |
Why?
|
| Molecular Sequence Data | 36 | 2015 | 18111 | 0.330 |
Why?
|
| Endogenous Retroviruses | 2 | 2020 | 112 | 0.320 |
Why?
|
| Lymphocyte Count | 6 | 2016 | 793 | 0.320 |
Why?
|
| Disease Susceptibility | 5 | 2019 | 1782 | 0.310 |
Why?
|
| Homeostasis | 11 | 2022 | 3339 | 0.310 |
Why?
|
| Adenocarcinoma | 3 | 2021 | 6364 | 0.310 |
Why?
|
| Germ-Line Mutation | 3 | 2014 | 1788 | 0.310 |
Why?
|
| Lymphoproliferative Disorders | 6 | 2009 | 524 | 0.310 |
Why?
|
| Malaria, Falciparum | 2 | 2016 | 1077 | 0.300 |
Why?
|
| Cell Lineage | 5 | 2022 | 2504 | 0.300 |
Why?
|
| Skin Neoplasms | 5 | 2021 | 5692 | 0.300 |
Why?
|
| Kidney Neoplasms | 5 | 2023 | 4262 | 0.300 |
Why?
|
| Gammaretrovirus | 2 | 2000 | 54 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 2725 | 0.290 |
Why?
|
| Cell Proliferation | 22 | 2022 | 10483 | 0.290 |
Why?
|
| Genetic Testing | 2 | 2021 | 3444 | 0.290 |
Why?
|
| Amino Acid Sequence | 26 | 2015 | 13814 | 0.290 |
Why?
|
| Lymphoid Tissue | 7 | 2006 | 455 | 0.280 |
Why?
|
| Receptors, Cell Surface | 5 | 2013 | 2865 | 0.280 |
Why?
|
| Stromal Cells | 4 | 2022 | 1355 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2017 | 3873 | 0.280 |
Why?
|
| Plasmodium falciparum | 2 | 2016 | 1732 | 0.280 |
Why?
|
| Retroviridae | 7 | 1999 | 914 | 0.270 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2023 | 266 | 0.270 |
Why?
|
| Glioblastoma | 4 | 2023 | 3481 | 0.270 |
Why?
|
| Mice, Inbred Strains | 11 | 2014 | 1828 | 0.270 |
Why?
|
| Aging | 5 | 2021 | 8664 | 0.260 |
Why?
|
| Encephalopathy, Bovine Spongiform | 1 | 2004 | 6 | 0.260 |
Why?
|
| Asthma | 9 | 2022 | 6010 | 0.260 |
Why?
|
| Exons | 7 | 2011 | 2439 | 0.260 |
Why?
|
| Sheep Diseases | 1 | 2004 | 18 | 0.260 |
Why?
|
| PrPSc Proteins | 1 | 2004 | 32 | 0.260 |
Why?
|
| Graft Survival | 12 | 2015 | 3737 | 0.250 |
Why?
|
| Central Nervous System Diseases | 5 | 2011 | 518 | 0.250 |
Why?
|
| Immunoglobulins | 4 | 2024 | 881 | 0.250 |
Why?
|
| Leishmania mexicana | 3 | 2014 | 31 | 0.250 |
Why?
|
| Adjuvants, Immunologic | 6 | 2014 | 1000 | 0.250 |
Why?
|
| OX40 Ligand | 7 | 2014 | 51 | 0.240 |
Why?
|
| Fibrinogen | 2 | 2020 | 894 | 0.240 |
Why?
|
| Formates | 1 | 2023 | 42 | 0.240 |
Why?
|
| Interferon Type I | 4 | 2023 | 542 | 0.230 |
Why?
|
| Genome | 1 | 2012 | 1807 | 0.230 |
Why?
|
| Transplantation Tolerance | 4 | 2013 | 617 | 0.230 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2023 | 13 | 0.230 |
Why?
|
| Multiple Sclerosis | 3 | 2016 | 3079 | 0.230 |
Why?
|
| Administration, Intranasal | 2 | 2020 | 446 | 0.230 |
Why?
|
| Endoplasmic Reticulum | 2 | 2020 | 1146 | 0.230 |
Why?
|
| Hepatic Stellate Cells | 2 | 2022 | 109 | 0.220 |
Why?
|
| Colorectal Neoplasms | 5 | 2023 | 6773 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2007 | 1677 | 0.220 |
Why?
|
| Germ-Free Life | 1 | 2023 | 188 | 0.220 |
Why?
|
| Friends | 1 | 2024 | 154 | 0.220 |
Why?
|
| Receptors, CXCR3 | 2 | 2014 | 237 | 0.220 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2022 | 17 | 0.210 |
Why?
|
| Mice, Mutant Strains | 18 | 2019 | 1865 | 0.210 |
Why?
|
| Gene Knockout Techniques | 2 | 2024 | 808 | 0.210 |
Why?
|
| Th17 Cells | 3 | 2015 | 766 | 0.210 |
Why?
|
| Immunization | 5 | 2015 | 1256 | 0.210 |
Why?
|
| Antineoplastic Agents | 4 | 2020 | 13693 | 0.210 |
Why?
|
| Protein Binding | 8 | 2023 | 9384 | 0.210 |
Why?
|
| Species Specificity | 6 | 2020 | 2478 | 0.210 |
Why?
|
| Maternal-Fetal Exchange | 5 | 2013 | 456 | 0.210 |
Why?
|
| Chronic Disease | 12 | 2022 | 9145 | 0.200 |
Why?
|
| Thymus Gland | 10 | 2009 | 1267 | 0.200 |
Why?
|
| Immunohistochemistry | 10 | 2019 | 11366 | 0.200 |
Why?
|
| Brassica | 3 | 1998 | 38 | 0.200 |
Why?
|
| Immunoglobulin G | 12 | 2019 | 4561 | 0.200 |
Why?
|
| Female | 87 | 2021 | 380193 | 0.200 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 200 | 0.200 |
Why?
|
| Virus Diseases | 4 | 2010 | 711 | 0.200 |
Why?
|
| Complementarity Determining Regions | 2 | 2022 | 149 | 0.200 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 70 | 0.190 |
Why?
|
| Precursor Cells, T-Lymphoid | 1 | 2021 | 20 | 0.190 |
Why?
|
| Proteins | 10 | 2022 | 6100 | 0.190 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2021 | 126 | 0.190 |
Why?
|
| Monocytes | 3 | 2022 | 2596 | 0.190 |
Why?
|
| Glycoproteins | 3 | 2005 | 2266 | 0.190 |
Why?
|
| Up-Regulation | 15 | 2015 | 4222 | 0.190 |
Why?
|
| Glutarates | 1 | 2022 | 236 | 0.190 |
Why?
|
| Pancreas | 2 | 2023 | 1687 | 0.190 |
Why?
|
| Apoptosis | 16 | 2016 | 9724 | 0.190 |
Why?
|
| Clonal Anergy | 1 | 2001 | 169 | 0.180 |
Why?
|
| DNA-Binding Proteins | 16 | 2020 | 9647 | 0.180 |
Why?
|
| Immunoglobulin M | 5 | 2018 | 1537 | 0.180 |
Why?
|
| Myofibroblasts | 1 | 2022 | 222 | 0.180 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2021 | 199 | 0.180 |
Why?
|
| Lung | 12 | 2022 | 9857 | 0.180 |
Why?
|
| Ebolavirus | 1 | 2022 | 263 | 0.180 |
Why?
|
| Macrophages | 10 | 2022 | 5660 | 0.180 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2000 | 94 | 0.180 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2022 | 871 | 0.180 |
Why?
|
| Lupus Nephritis | 4 | 2011 | 310 | 0.180 |
Why?
|
| Leukopoiesis | 2 | 1998 | 56 | 0.180 |
Why?
|
| GPI-Linked Proteins | 2 | 2018 | 435 | 0.170 |
Why?
|
| Fibroblasts | 6 | 2019 | 4162 | 0.170 |
Why?
|
| Receptors, OX40 | 4 | 2014 | 43 | 0.170 |
Why?
|
| Zidovudine | 6 | 1993 | 620 | 0.170 |
Why?
|
| Mice, SCID | 7 | 2016 | 2716 | 0.170 |
Why?
|
| Epitopes, T-Lymphocyte | 9 | 2012 | 880 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-maf | 2 | 2009 | 71 | 0.170 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2019 | 42 | 0.170 |
Why?
|
| Histone Demethylases | 2 | 2020 | 321 | 0.170 |
Why?
|
| HLA-B7 Antigen | 1 | 1998 | 48 | 0.170 |
Why?
|
| Herpes Simplex | 2 | 2014 | 470 | 0.170 |
Why?
|
| Hypersensitivity | 4 | 2019 | 1102 | 0.170 |
Why?
|
| Integrases | 1 | 2021 | 533 | 0.170 |
Why?
|
| Viruses | 1 | 2022 | 375 | 0.170 |
Why?
|
| Peptide Fragments | 8 | 2009 | 5096 | 0.170 |
Why?
|
| CD40 Ligand | 8 | 2008 | 526 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2021 | 2916 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2021 | 4424 | 0.170 |
Why?
|
| Cricetinae | 7 | 2012 | 2475 | 0.160 |
Why?
|
| Transplantation, Homologous | 12 | 2017 | 4777 | 0.160 |
Why?
|
| Transplantation Chimera | 2 | 2019 | 613 | 0.160 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 7721 | 0.160 |
Why?
|
| Genes, Viral | 7 | 1991 | 718 | 0.160 |
Why?
|
| Receptor Cross-Talk | 2 | 2016 | 119 | 0.160 |
Why?
|
| Citrobacter rodentium | 1 | 2018 | 66 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2938 | 0.160 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2018 | 55 | 0.160 |
Why?
|
| Gene Deletion | 6 | 2020 | 2751 | 0.160 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 890 | 0.160 |
Why?
|
| CHO Cells | 6 | 2012 | 1409 | 0.160 |
Why?
|
| Vero Cells | 1 | 2019 | 485 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2018 | 193 | 0.160 |
Why?
|
| Natural Killer T-Cells | 2 | 2013 | 316 | 0.160 |
Why?
|
| Extinction, Psychological | 1 | 2001 | 376 | 0.160 |
Why?
|
| Osteoclasts | 1 | 2022 | 729 | 0.160 |
Why?
|
| Alleles | 4 | 2022 | 6933 | 0.160 |
Why?
|
| Cell Cycle | 4 | 2003 | 2967 | 0.160 |
Why?
|
| Cell Division | 10 | 2002 | 4569 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 6 | 2006 | 573 | 0.150 |
Why?
|
| Plasma Cells | 2 | 2012 | 591 | 0.150 |
Why?
|
| Mice, Congenic | 3 | 2019 | 99 | 0.150 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 3646 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2020 | 520 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2021 | 2504 | 0.150 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2022 | 428 | 0.150 |
Why?
|
| Alanine | 1 | 2019 | 572 | 0.150 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2016 | 810 | 0.150 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2016 | 18 | 0.150 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1996 | 76 | 0.150 |
Why?
|
| Colitis | 4 | 2011 | 1170 | 0.150 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2022 | 1366 | 0.140 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2014 | 274 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 2 | 2014 | 743 | 0.140 |
Why?
|
| Lymphocyte Depletion | 5 | 2017 | 608 | 0.140 |
Why?
|
| Immunoglobulin Idiotypes | 3 | 1986 | 201 | 0.140 |
Why?
|
| Receptors, Virus | 5 | 2011 | 649 | 0.140 |
Why?
|
| Gene Expression | 9 | 2019 | 7798 | 0.140 |
Why?
|
| STAT6 Transcription Factor | 5 | 2004 | 199 | 0.140 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2016 | 91 | 0.140 |
Why?
|
| Mammalian orthoreovirus 3 | 8 | 1986 | 44 | 0.140 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 187 | 0.140 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 410 | 0.140 |
Why?
|
| RNA, Messenger | 17 | 2012 | 13035 | 0.140 |
Why?
|
| Peyer's Patches | 4 | 2015 | 121 | 0.140 |
Why?
|
| Selenoproteins | 1 | 2018 | 216 | 0.140 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 4253 | 0.140 |
Why?
|
| Reoviridae Infections | 6 | 1990 | 60 | 0.140 |
Why?
|
| Carbon | 2 | 2018 | 687 | 0.140 |
Why?
|
| RNA | 5 | 2022 | 2749 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2021 | 971 | 0.140 |
Why?
|
| Cell Membrane | 2 | 2016 | 3749 | 0.140 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 3707 | 0.140 |
Why?
|
| Schistosomiasis mansoni | 2 | 2011 | 85 | 0.140 |
Why?
|
| Brain Edema | 1 | 2020 | 617 | 0.140 |
Why?
|
| Gene Products, gag | 1 | 1996 | 337 | 0.140 |
Why?
|
| RNA Virus Infections | 1 | 2015 | 17 | 0.140 |
Why?
|
| Receptors, CCR | 2 | 2013 | 38 | 0.140 |
Why?
|
| Immunosuppressive Agents | 8 | 2011 | 4153 | 0.130 |
Why?
|
| Viral Vaccines | 3 | 2014 | 636 | 0.130 |
Why?
|
| Base Sequence | 17 | 2004 | 12797 | 0.130 |
Why?
|
| Prion Diseases | 1 | 1996 | 88 | 0.130 |
Why?
|
| Plant Proteins | 2 | 1996 | 364 | 0.130 |
Why?
|
| Endothelial Cells | 6 | 2021 | 3486 | 0.130 |
Why?
|
| RNA, Viral | 9 | 2013 | 2901 | 0.130 |
Why?
|
| Behavior, Addictive | 1 | 2001 | 462 | 0.130 |
Why?
|
| Autoantigens | 4 | 2019 | 892 | 0.130 |
Why?
|
| Cloning, Molecular | 10 | 2004 | 4320 | 0.130 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 601 | 0.130 |
Why?
|
| Cell Separation | 4 | 2015 | 1751 | 0.130 |
Why?
|
| Haptens | 3 | 2001 | 166 | 0.130 |
Why?
|
| Influenza A virus | 3 | 2014 | 456 | 0.130 |
Why?
|
| Viscera | 1 | 1995 | 139 | 0.130 |
Why?
|
| Retinal Ganglion Cells | 2 | 2012 | 770 | 0.130 |
Why?
|
| Genomic Islands | 1 | 2015 | 51 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4208 | 0.130 |
Why?
|
| Cell Culture Techniques | 3 | 2022 | 1678 | 0.120 |
Why?
|
| Acyl Coenzyme A | 1 | 1994 | 55 | 0.120 |
Why?
|
| Cell Death | 1 | 2020 | 1707 | 0.120 |
Why?
|
| Emulsions | 1 | 2015 | 156 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 3 | 2021 | 147 | 0.120 |
Why?
|
| Cell Line | 12 | 2021 | 16000 | 0.120 |
Why?
|
| Mice, Inbred MRL lpr | 7 | 2013 | 159 | 0.120 |
Why?
|
| Silicones | 1 | 2015 | 250 | 0.120 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 154 | 0.120 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2013 | 109 | 0.120 |
Why?
|
| Lymphocyte Culture Test, Mixed | 5 | 2001 | 518 | 0.120 |
Why?
|
| Microtubules | 3 | 2013 | 1089 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1276 | 0.120 |
Why?
|
| Phenotype | 11 | 2021 | 16367 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1510 | 0.120 |
Why?
|
| Antigens, Helminth | 2 | 2011 | 64 | 0.120 |
Why?
|
| Tumor Necrosis Factors | 6 | 2004 | 109 | 0.120 |
Why?
|
| Immunity, Cellular | 6 | 2018 | 1607 | 0.120 |
Why?
|
| Interleukin-23 | 2 | 2012 | 194 | 0.110 |
Why?
|
| Lipids | 2 | 2023 | 3307 | 0.110 |
Why?
|
| Dexamethasone | 1 | 2020 | 1951 | 0.110 |
Why?
|
| Mice, 129 Strain | 2 | 2011 | 386 | 0.110 |
Why?
|
| Interleukin-17 | 4 | 2012 | 901 | 0.110 |
Why?
|
| Carboxy-Lyases | 1 | 2013 | 90 | 0.110 |
Why?
|
| Nematospiroides dubius | 3 | 2003 | 35 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2012 | 0.110 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2182 | 0.110 |
Why?
|
| Rodent Diseases | 1 | 1993 | 57 | 0.110 |
Why?
|
| Pneumonia | 2 | 2019 | 2133 | 0.110 |
Why?
|
| Enterotoxins | 3 | 2004 | 368 | 0.110 |
Why?
|
| Apyrase | 1 | 2015 | 364 | 0.110 |
Why?
|
| Recombination, Genetic | 6 | 2014 | 1586 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 720 | 0.110 |
Why?
|
| Male | 46 | 2021 | 350115 | 0.110 |
Why?
|
| Autophagy | 1 | 2020 | 1297 | 0.110 |
Why?
|
| Conserved Sequence | 4 | 2012 | 1202 | 0.110 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2008 | 319 | 0.110 |
Why?
|
| Intestinal Diseases, Parasitic | 2 | 2003 | 66 | 0.110 |
Why?
|
| Cell Survival | 7 | 2019 | 5882 | 0.110 |
Why?
|
| Transplantation Immunology | 2 | 2005 | 546 | 0.110 |
Why?
|
| Founder Effect | 1 | 2013 | 189 | 0.110 |
Why?
|
| Motor Neuron Disease | 1 | 1993 | 99 | 0.110 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 70 | 0.110 |
Why?
|
| Carrier Proteins | 4 | 2009 | 5023 | 0.110 |
Why?
|
| Mitochondria | 5 | 2021 | 3514 | 0.110 |
Why?
|
| Atherosclerosis | 4 | 2011 | 3444 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1375 | 0.100 |
Why?
|
| Genes, Plant | 3 | 1998 | 124 | 0.100 |
Why?
|
| Blotting, Southern | 4 | 2014 | 803 | 0.100 |
Why?
|
| Microglia | 2 | 1999 | 1267 | 0.100 |
Why?
|
| Cell Surface Extensions | 1 | 2012 | 67 | 0.100 |
Why?
|
| Chromosome Mapping | 5 | 1997 | 4740 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2917 | 0.100 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 209 | 0.100 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 994 | 0.100 |
Why?
|
| Organ Specificity | 3 | 2017 | 2008 | 0.100 |
Why?
|
| Cross-Priming | 2 | 2012 | 82 | 0.100 |
Why?
|
| Teaching | 1 | 2019 | 1174 | 0.100 |
Why?
|
| Enteritis | 2 | 2012 | 165 | 0.100 |
Why?
|
| Interleukin-1beta | 3 | 2012 | 972 | 0.100 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2022 | 88 | 0.100 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 576 | 0.100 |
Why?
|
| Helicobacter pylori | 1 | 2015 | 383 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1862 | 0.100 |
Why?
|
| Immunoglobulin E | 7 | 2019 | 1463 | 0.100 |
Why?
|
| Immune Evasion | 1 | 2015 | 360 | 0.100 |
Why?
|
| Transcription Factors | 9 | 2020 | 12207 | 0.100 |
Why?
|
| Genetic Vectors | 3 | 2019 | 3424 | 0.100 |
Why?
|
| Gene Targeting | 7 | 2001 | 880 | 0.100 |
Why?
|
| Cell Movement | 11 | 2022 | 5218 | 0.100 |
Why?
|
| Inbreeding | 1 | 2011 | 49 | 0.100 |
Why?
|
| Immunophenotyping | 5 | 2017 | 1880 | 0.100 |
Why?
|
| Interleukin-3 | 1 | 2012 | 444 | 0.100 |
Why?
|
| Muscle Cells | 1 | 2012 | 197 | 0.100 |
Why?
|
| Interphase | 2 | 2002 | 226 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2023 | 3296 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2013 | 4751 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2021 | 2110 | 0.100 |
Why?
|
| Transfection | 7 | 2012 | 5895 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2015 | 981 | 0.090 |
Why?
|
| Inflammation | 11 | 2022 | 10637 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11525 | 0.090 |
Why?
|
| Helminth Proteins | 1 | 2011 | 171 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8432 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2021 | 1887 | 0.090 |
Why?
|
| Vaccines, Synthetic | 4 | 2014 | 634 | 0.090 |
Why?
|
| Schistosoma mansoni | 1 | 2011 | 149 | 0.090 |
Why?
|
| Trans-Activators | 6 | 2004 | 2926 | 0.090 |
Why?
|
| Cochlear Implants | 1 | 2015 | 339 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2020 | 2505 | 0.090 |
Why?
|
| Gene Expression Profiling | 7 | 2017 | 9445 | 0.090 |
Why?
|
| Strongylida Infections | 4 | 2003 | 46 | 0.090 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 8861 | 0.090 |
Why?
|
| Central Nervous System | 4 | 2003 | 1357 | 0.090 |
Why?
|
| Tumor Burden | 3 | 2023 | 1915 | 0.090 |
Why?
|
| Sirtuins | 1 | 2013 | 323 | 0.090 |
Why?
|
| Myeloid Cells | 3 | 2021 | 810 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 589 | 0.090 |
Why?
|
| Trigeminal Ganglion | 1 | 2011 | 186 | 0.090 |
Why?
|
| Genetic Linkage | 4 | 2008 | 2421 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2015 | 1767 | 0.090 |
Why?
|
| Islets of Langerhans | 2 | 2009 | 1352 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1029 | 0.090 |
Why?
|
| Retina | 2 | 2012 | 2616 | 0.090 |
Why?
|
| Granulocytes | 1 | 2011 | 548 | 0.090 |
Why?
|
| MicroRNAs | 3 | 2017 | 3751 | 0.090 |
Why?
|
| Oxidation-Reduction | 3 | 2023 | 2184 | 0.090 |
Why?
|
| Prognosis | 6 | 2020 | 29060 | 0.090 |
Why?
|
| Pneumococcal Infections | 1 | 2014 | 497 | 0.090 |
Why?
|
| Crosses, Genetic | 9 | 2007 | 791 | 0.090 |
Why?
|
| Hypersensitivity, Delayed | 4 | 2009 | 484 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2023 | 2043 | 0.090 |
Why?
|
| Mast-Cell Sarcoma | 2 | 1999 | 47 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2007 | 2839 | 0.090 |
Why?
|
| Immune Sera | 4 | 2007 | 641 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2015 | 2455 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5077 | 0.080 |
Why?
|
| Antigens, T-Independent | 2 | 1999 | 21 | 0.080 |
Why?
|
| Vaccines, DNA | 2 | 2000 | 305 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8642 | 0.080 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 2 | 2022 | 24 | 0.080 |
Why?
|
| Dermatitis, Contact | 2 | 1999 | 129 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 1 | 2014 | 714 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2016 | 17446 | 0.080 |
Why?
|
| Uveitis, Posterior | 1 | 2009 | 44 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 459 | 0.080 |
Why?
|
| Genomics | 3 | 2020 | 5717 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2023 | 548 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 2 | 2015 | 1031 | 0.080 |
Why?
|
| Intestinal Mucosa | 6 | 2013 | 3037 | 0.080 |
Why?
|
| Leukemia, Experimental | 1 | 1989 | 246 | 0.080 |
Why?
|
| Mice, Inbred C3H | 5 | 2015 | 964 | 0.080 |
Why?
|
| Epitopes | 4 | 2021 | 2571 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 6 | 2020 | 1475 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2001 | 3966 | 0.080 |
Why?
|
| Muscle Proteins | 3 | 2003 | 1158 | 0.080 |
Why?
|
| Graft Enhancement, Immunologic | 2 | 2007 | 59 | 0.080 |
Why?
|
| Virus Latency | 1 | 2011 | 358 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2460 | 0.080 |
Why?
|
| Liver | 8 | 2014 | 7475 | 0.080 |
Why?
|
| Interleukin-12 | 2 | 2008 | 580 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 1877 | 0.080 |
Why?
|
| Melanocytes | 3 | 2021 | 515 | 0.080 |
Why?
|
| Cell Transformation, Viral | 3 | 1989 | 567 | 0.080 |
Why?
|
| Blotting, Western | 7 | 2016 | 5181 | 0.080 |
Why?
|
| Antiviral Agents | 3 | 1991 | 2987 | 0.080 |
Why?
|
| Membrane Proteins | 7 | 2007 | 7882 | 0.080 |
Why?
|
| DNA Primers | 6 | 2014 | 2891 | 0.070 |
Why?
|
| Placenta | 2 | 2013 | 1699 | 0.070 |
Why?
|
| Bone Marrow Cells | 7 | 2016 | 2513 | 0.070 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 437 | 0.070 |
Why?
|
| Thymidine | 1 | 1987 | 310 | 0.070 |
Why?
|
| Toll-Like Receptors | 2 | 2008 | 593 | 0.070 |
Why?
|
| Phosphorylation | 5 | 2021 | 8436 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2009 | 3617 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 1023 | 0.070 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2007 | 102 | 0.070 |
Why?
|
| Protein Isoforms | 4 | 2011 | 1730 | 0.070 |
Why?
|
| DNA, Complementary | 5 | 1997 | 2050 | 0.070 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1986 | 349 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2009 | 675 | 0.070 |
Why?
|
| Superantigens | 2 | 2004 | 129 | 0.070 |
Why?
|
| Embryo, Mammalian | 7 | 2001 | 1701 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2007 | 193 | 0.070 |
Why?
|
| Keratitis | 1 | 2009 | 268 | 0.070 |
Why?
|
| Sequence Deletion | 3 | 2012 | 1525 | 0.070 |
Why?
|
| Curriculum | 1 | 2019 | 3605 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 1982 | 1185 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2017 | 226 | 0.070 |
Why?
|
| Chemokines | 4 | 2021 | 970 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3712 | 0.070 |
Why?
|
| Proteome | 1 | 2016 | 1798 | 0.070 |
Why?
|
| Fetal Diseases | 2 | 1993 | 903 | 0.070 |
Why?
|
| Injections, Intravenous | 2 | 2005 | 1420 | 0.070 |
Why?
|
| Immunization, Secondary | 4 | 2004 | 340 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2022 | 310 | 0.070 |
Why?
|
| Virus Replication | 6 | 2013 | 2535 | 0.070 |
Why?
|
| Chromatin | 3 | 2018 | 2933 | 0.070 |
Why?
|
| Age Factors | 3 | 2020 | 18373 | 0.070 |
Why?
|
| RNA Interference | 1 | 2014 | 2890 | 0.070 |
Why?
|
| Stem Cells | 8 | 2000 | 3567 | 0.070 |
Why?
|
| Bacterial Toxins | 2 | 2002 | 931 | 0.070 |
Why?
|
| NFATC Transcription Factors | 3 | 2017 | 381 | 0.070 |
Why?
|
| Mice, Inbred CBA | 3 | 2013 | 448 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 4328 | 0.070 |
Why?
|
| Myelin Proteins | 2 | 2012 | 215 | 0.070 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2005 | 60 | 0.070 |
Why?
|
| Antigens, CD1 | 1 | 2008 | 437 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 2 | 2012 | 2007 | 0.070 |
Why?
|
| Moloney murine leukemia virus | 3 | 1991 | 139 | 0.070 |
Why?
|
| Calcium Signaling | 2 | 2012 | 721 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2020 | 10943 | 0.070 |
Why?
|
| Coculture Techniques | 4 | 2016 | 1341 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 4459 | 0.060 |
Why?
|
| Interleukin-13 | 2 | 2019 | 389 | 0.060 |
Why?
|
| Integrin alpha Chains | 1 | 2005 | 97 | 0.060 |
Why?
|
| Virulence | 3 | 2014 | 1333 | 0.060 |
Why?
|
| Acute Disease | 3 | 2013 | 7147 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2009 | 1783 | 0.060 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2004 | 200 | 0.060 |
Why?
|
| Antigens, Viral | 5 | 1990 | 1035 | 0.060 |
Why?
|
| Dry Eye Syndromes | 1 | 2009 | 386 | 0.060 |
Why?
|
| Exosomes | 1 | 2009 | 417 | 0.060 |
Why?
|
| Nephrotic Syndrome | 2 | 2004 | 389 | 0.060 |
Why?
|
| Ireland | 1 | 2004 | 161 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13104 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 1 | 2005 | 175 | 0.060 |
Why?
|
| Bone Marrow | 3 | 2011 | 2948 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1889 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2017 | 2789 | 0.060 |
Why?
|
| Energy Metabolism | 3 | 2022 | 2897 | 0.060 |
Why?
|
| Nerve Growth Factors | 2 | 2021 | 574 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2016 | 1832 | 0.060 |
Why?
|
| Tumor Virus Infections | 1 | 1987 | 454 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2000 | 1159 | 0.060 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2005 | 150 | 0.060 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2000 | 370 | 0.060 |
Why?
|
| Transduction, Genetic | 3 | 2014 | 913 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2016 | 768 | 0.060 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2001 | 158 | 0.060 |
Why?
|
| DNA | 10 | 2004 | 7294 | 0.060 |
Why?
|
| Malaria | 1 | 2013 | 1239 | 0.060 |
Why?
|
| Phagocytosis | 2 | 2007 | 1539 | 0.060 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2023 | 39 | 0.060 |
Why?
|
| Medulla Oblongata | 1 | 2004 | 243 | 0.060 |
Why?
|
| Murine Acquired Immunodeficiency Syndrome | 1 | 2002 | 4 | 0.060 |
Why?
|
| Models, Animal | 2 | 2008 | 2173 | 0.060 |
Why?
|
| Nippostrongylus | 1 | 2002 | 23 | 0.060 |
Why?
|
| Tissue Distribution | 5 | 2005 | 2327 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2019 | 6234 | 0.060 |
Why?
|
| Corneal Transplantation | 1 | 2007 | 386 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2017 | 1683 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 182 | 0.060 |
Why?
|
| Software | 1 | 2017 | 4441 | 0.060 |
Why?
|
| Virus Inactivation | 1 | 2022 | 20 | 0.060 |
Why?
|
| Sarcoma | 1 | 2014 | 1897 | 0.060 |
Why?
|
| Candidiasis | 2 | 2002 | 366 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2014 | 1479 | 0.060 |
Why?
|
| Drug Therapy, Combination | 3 | 2022 | 6489 | 0.060 |
Why?
|
| Integrins | 3 | 1996 | 846 | 0.060 |
Why?
|
| Mutation | 14 | 2023 | 29786 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 625 | 0.050 |
Why?
|
| Pyruvate Carboxylase | 1 | 2022 | 17 | 0.050 |
Why?
|
| Candida albicans | 2 | 2002 | 394 | 0.050 |
Why?
|
| Leukemia Virus, Murine | 1 | 2002 | 117 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 244 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 2 | 2001 | 438 | 0.050 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2022 | 49 | 0.050 |
Why?
|
| Ultraviolet Rays | 2 | 2005 | 1060 | 0.050 |
Why?
|
| Calcineurin | 1 | 2003 | 226 | 0.050 |
Why?
|
| Animals, Newborn | 4 | 2009 | 2726 | 0.050 |
Why?
|
| GATA6 Transcription Factor | 1 | 2022 | 50 | 0.050 |
Why?
|
| Litter Size | 2 | 2013 | 54 | 0.050 |
Why?
|
| Brain | 3 | 2009 | 26388 | 0.050 |
Why?
|
| Tissue Donors | 3 | 2007 | 2241 | 0.050 |
Why?
|
| Neutrophils | 5 | 2021 | 3721 | 0.050 |
Why?
|
| Proto-Oncogenes | 2 | 1996 | 321 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2020 | 2850 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 20824 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2017 | 783 | 0.050 |
Why?
|
| Glycerol | 1 | 2023 | 278 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2017 | 2499 | 0.050 |
Why?
|
| Sheep | 1 | 2004 | 1437 | 0.050 |
Why?
|
| COS Cells | 3 | 2013 | 1161 | 0.050 |
Why?
|
| Succinic Acid | 1 | 2022 | 82 | 0.050 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2013 | 298 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 1142 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2024 | 208 | 0.050 |
Why?
|
| Antibodies | 3 | 2013 | 2460 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 1996 | 1950 | 0.050 |
Why?
|
| HIV Infections | 2 | 2015 | 16715 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2011 | 1580 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2022 | 424 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 1999 | 1101 | 0.050 |
Why?
|
| Mice, Inbred DBA | 3 | 1999 | 642 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 294 | 0.050 |
Why?
|
| Toxoplasma | 1 | 2022 | 150 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 323 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 4463 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2005 | 547 | 0.050 |
Why?
|
| RNA, Double-Stranded | 2 | 2018 | 290 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 299 | 0.050 |
Why?
|
| Pigmentation | 2 | 1991 | 148 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2004 | 794 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1434 | 0.050 |
Why?
|
| Glycolysis | 2 | 2016 | 829 | 0.050 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2020 | 86 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 402 | 0.050 |
Why?
|
| S Phase | 1 | 2002 | 423 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2001 | 387 | 0.050 |
Why?
|
| Exotoxins | 1 | 1980 | 119 | 0.050 |
Why?
|
| Cycloheximide | 1 | 1980 | 347 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 2638 | 0.050 |
Why?
|
| G1 Phase | 1 | 2002 | 415 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2022 | 314 | 0.050 |
Why?
|
| Pyrimidinones | 1 | 2023 | 370 | 0.050 |
Why?
|
| Macrophage-1 Antigen | 2 | 2002 | 290 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2000 | 329 | 0.050 |
Why?
|
| Fetal Death | 3 | 1997 | 448 | 0.050 |
Why?
|
| Stem Cell Niche | 1 | 2024 | 346 | 0.050 |
Why?
|
| Chromosome Deletion | 2 | 2020 | 1401 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1656 | 0.050 |
Why?
|
| Obesity | 2 | 2020 | 12746 | 0.050 |
Why?
|
| Hemagglutinins, Viral | 1 | 1980 | 67 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2002 | 3464 | 0.040 |
Why?
|
| Contractile Proteins | 1 | 2001 | 246 | 0.040 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 2086 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 647 | 0.040 |
Why?
|
| Diphtheria Toxin | 1 | 1980 | 255 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1997 | 4554 | 0.040 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2005 | 379 | 0.040 |
Why?
|
| Genes, env | 1 | 1999 | 95 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1998 | 343 | 0.040 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 1999 | 113 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2010 | 3524 | 0.040 |
Why?
|
| Cyclins | 1 | 2002 | 603 | 0.040 |
Why?
|
| Phosphates | 1 | 2023 | 785 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1092 | 0.040 |
Why?
|
| Fatty Acids | 2 | 2020 | 1809 | 0.040 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2019 | 100 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2000 | 201 | 0.040 |
Why?
|
| NAD | 1 | 2023 | 590 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 1997 | 6171 | 0.040 |
Why?
|
| Pyroglyphidae | 1 | 2019 | 88 | 0.040 |
Why?
|
| Antibodies, Viral | 3 | 2017 | 3177 | 0.040 |
Why?
|
| Forelimb | 1 | 1999 | 122 | 0.040 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2000 | 952 | 0.040 |
Why?
|
| Blotting, Northern | 3 | 1999 | 1581 | 0.040 |
Why?
|
| Neural Crest | 2 | 1991 | 275 | 0.040 |
Why?
|
| Jurkat Cells | 2 | 2016 | 743 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2020 | 380 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6539 | 0.040 |
Why?
|
| Viremia | 2 | 2013 | 736 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 2019 | 187 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2005 | 1059 | 0.040 |
Why?
|
| Isoantigens | 1 | 2001 | 567 | 0.040 |
Why?
|
| Cattle | 1 | 2004 | 3922 | 0.040 |
Why?
|
| Interleukin-5 | 2 | 2015 | 273 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 1999 | 279 | 0.040 |
Why?
|
| Hematopoiesis | 3 | 1997 | 2073 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 2 | 1995 | 1602 | 0.040 |
Why?
|
| Blood Cells | 2 | 2017 | 309 | 0.040 |
Why?
|
| Fibrosis | 1 | 2005 | 2029 | 0.040 |
Why?
|
| Edema | 1 | 2023 | 789 | 0.040 |
Why?
|
| Vaccinia virus | 1 | 2000 | 349 | 0.040 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2020 | 290 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2007 | 2256 | 0.040 |
Why?
|
| Scleroderma, Localized | 1 | 2019 | 79 | 0.040 |
Why?
|
| England | 1 | 2019 | 522 | 0.040 |
Why?
|
| Genes, Lethal | 2 | 1996 | 242 | 0.040 |
Why?
|
| Thymidine Kinase | 1 | 2018 | 290 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 671 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2020 | 535 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5223 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 426 | 0.040 |
Why?
|
| Digestive System | 1 | 1999 | 253 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 473 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 1999 | 333 | 0.040 |
Why?
|
| Knowledge | 1 | 2019 | 181 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 711 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 1999 | 471 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2004 | 1539 | 0.040 |
Why?
|
| Yellow fever virus | 1 | 2017 | 22 | 0.040 |
Why?
|
| Streptococcus agalactiae | 1 | 1999 | 375 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2005 | 3914 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2019 | 315 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 3554 | 0.040 |
Why?
|
| Genes, MHC Class II | 2 | 2012 | 457 | 0.040 |
Why?
|
| Factor VIII | 1 | 2000 | 347 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 2088 | 0.040 |
Why?
|
| Adipose Tissue | 2 | 2019 | 3280 | 0.040 |
Why?
|
| Lymphangiogenesis | 1 | 2018 | 174 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 940 | 0.040 |
Why?
|
| Blood Platelets | 2 | 2001 | 2509 | 0.040 |
Why?
|
| Receptors, Cytokine | 2 | 2012 | 262 | 0.040 |
Why?
|
| Glucose | 3 | 2019 | 4398 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1284 | 0.040 |
Why?
|
| Microinjections | 3 | 1993 | 327 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1996 | 2126 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2018 | 252 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1989 | 2026 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 449 | 0.040 |
Why?
|
| Hindlimb | 1 | 1999 | 504 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2021 | 10252 | 0.040 |
Why?
|
| Freund's Adjuvant | 1 | 1997 | 139 | 0.040 |
Why?
|
| Kinetics | 3 | 2020 | 6476 | 0.040 |
Why?
|
| Ikaros Transcription Factor | 2 | 1996 | 217 | 0.040 |
Why?
|
| AIDS Vaccines | 2 | 2000 | 938 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2000 | 549 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2022 | 1132 | 0.040 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 135 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2003 | 745 | 0.040 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1999 | 578 | 0.040 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2016 | 43 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 1999 | 610 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2003 | 5856 | 0.040 |
Why?
|
| Milk | 2 | 1990 | 450 | 0.040 |
Why?
|
| Granuloma | 1 | 1999 | 319 | 0.040 |
Why?
|
| Glycosylation | 1 | 2000 | 1128 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2011 | 1799 | 0.040 |
Why?
|
| Hemophilia A | 1 | 2000 | 351 | 0.040 |
Why?
|
| Pregnancy | 11 | 2013 | 29144 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2021 | 495 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1997 | 323 | 0.040 |
Why?
|
| Angiomyolipoma | 1 | 2018 | 190 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 1998 | 262 | 0.040 |
Why?
|
| Intestines | 3 | 2013 | 1924 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2017 | 220 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2007 | 2148 | 0.030 |
Why?
|
| Vidarabine | 1 | 1998 | 345 | 0.030 |
Why?
|
| Peroxides | 1 | 2016 | 74 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2001 | 711 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 838 | 0.030 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2076 | 0.030 |
Why?
|
| Kidney Glomerulus | 3 | 2011 | 697 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 2015 | 43 | 0.030 |
Why?
|
| Genes, ras | 2 | 1989 | 690 | 0.030 |
Why?
|
| Radiation Chimera | 2 | 2008 | 223 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2020 | 1460 | 0.030 |
Why?
|
| Epithelium | 2 | 1999 | 1679 | 0.030 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 210 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 670 | 0.030 |
Why?
|
| Insulin Resistance | 2 | 2019 | 3864 | 0.030 |
Why?
|
| Harmine | 1 | 2015 | 11 | 0.030 |
Why?
|
| Parasitemia | 1 | 2016 | 173 | 0.030 |
Why?
|
| Cytarabine | 1 | 1998 | 692 | 0.030 |
Why?
|
| Perineum | 1 | 2017 | 211 | 0.030 |
Why?
|
| Skin | 5 | 2017 | 4372 | 0.030 |
Why?
|
| Hygromycin B | 1 | 1995 | 11 | 0.030 |
Why?
|
| Lymphoma | 1 | 2005 | 1877 | 0.030 |
Why?
|
| Pliability | 1 | 2015 | 63 | 0.030 |
Why?
|
| Quality of Life | 1 | 2017 | 12802 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 1995 | 707 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1995 | 74 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 63107 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 1050 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 1995 | 192 | 0.030 |
Why?
|
| Receptors, LDL | 2 | 2011 | 476 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 1152 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1162 | 0.030 |
Why?
|
| Proteomics | 2 | 2020 | 3638 | 0.030 |
Why?
|
| Plasmids | 1 | 2000 | 2308 | 0.030 |
Why?
|
| Thymoma | 1 | 1997 | 186 | 0.030 |
Why?
|
| Allantois | 1 | 1995 | 33 | 0.030 |
Why?
|
| Receptors, Chemokine | 2 | 2012 | 670 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 234 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1097 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1525 | 0.030 |
Why?
|
| Mice, Inbred AKR | 1 | 1994 | 107 | 0.030 |
Why?
|
| Adamantane | 1 | 2016 | 173 | 0.030 |
Why?
|
| Cinnamates | 1 | 1995 | 60 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 143 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1995 | 121 | 0.030 |
Why?
|
| Amino Acids | 1 | 2021 | 1737 | 0.030 |
Why?
|
| Kidney | 4 | 2004 | 7184 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 634 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 11726 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 2015 | 322 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 1453 | 0.030 |
Why?
|
| Arabidopsis | 1 | 1998 | 459 | 0.030 |
Why?
|
| Peer Group | 1 | 2019 | 635 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1987 | 2408 | 0.030 |
Why?
|
| Chorion | 1 | 1995 | 117 | 0.030 |
Why?
|
| Genomic Library | 1 | 1994 | 193 | 0.030 |
Why?
|
| Body Patterning | 1 | 1999 | 626 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2000 | 861 | 0.030 |
Why?
|
| Reaction Time | 1 | 2001 | 2098 | 0.030 |
Why?
|
| Eosinophils | 2 | 2014 | 955 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2000 | 1031 | 0.030 |
Why?
|
| Skull | 1 | 1999 | 814 | 0.030 |
Why?
|
| Gelsolin | 1 | 1995 | 190 | 0.030 |
Why?
|
| Antibodies, Antinuclear | 3 | 2000 | 326 | 0.030 |
Why?
|
| Nitric Oxide | 2 | 2019 | 2132 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2018 | 353 | 0.030 |
Why?
|
| Calcium | 3 | 2017 | 5755 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1997 | 268 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2022 | 3799 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 259 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 5867 | 0.030 |
Why?
|
| Chimera | 2 | 1997 | 485 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 894 | 0.030 |
Why?
|
| Survival Rate | 3 | 2020 | 12788 | 0.030 |
Why?
|
| Pyrimidines | 2 | 2016 | 2943 | 0.030 |
Why?
|
| STAT4 Transcription Factor | 2 | 2004 | 96 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2006 | 1911 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 1996 | 424 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 1572 | 0.030 |
Why?
|
| Immunocompetence | 1 | 2014 | 136 | 0.030 |
Why?
|
| Dermis | 1 | 2015 | 207 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2015 | 250 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1999 | 1073 | 0.030 |
Why?
|
| Cats | 1 | 2015 | 1000 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2000 | 1572 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 1335 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3921 | 0.030 |
Why?
|
| Hybridomas | 2 | 1985 | 452 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1999 | 1470 | 0.030 |
Why?
|
| Interferons | 1 | 2017 | 706 | 0.030 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2013 | 55 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 1995 | 180 | 0.030 |
Why?
|
| Nephritis | 2 | 2007 | 159 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2014 | 253 | 0.030 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2013 | 363 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2000 | 1184 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2013 | 59 | 0.030 |
Why?
|
| Vaccination | 3 | 2000 | 3279 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 2013 | 229 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 579 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 123 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1994 | 1375 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 3 | 2009 | 4805 | 0.030 |
Why?
|
| Electrodes | 1 | 2015 | 619 | 0.030 |
Why?
|
| beta-Thalassemia | 1 | 1995 | 225 | 0.030 |
Why?
|
| Animals, Wild | 1 | 1993 | 90 | 0.030 |
Why?
|
| Rats | 2 | 2001 | 24252 | 0.030 |
Why?
|
| Aged | 6 | 2022 | 163288 | 0.030 |
Why?
|
| Receptor Aggregation | 1 | 2012 | 80 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1995 | 436 | 0.030 |
Why?
|
| Antibody Specificity | 3 | 2003 | 1095 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2013 | 245 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1994 | 300 | 0.030 |
Why?
|
| Hypercholesterolemia | 2 | 2011 | 1151 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 350 | 0.030 |
Why?
|
| Bystander Effect | 1 | 2012 | 81 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2003 | 425 | 0.030 |
Why?
|
| Heparin | 1 | 1999 | 1637 | 0.030 |
Why?
|
| Mast Cells | 1 | 1999 | 1544 | 0.030 |
Why?
|
| Respiration | 1 | 2018 | 1653 | 0.030 |
Why?
|
| DNA, Viral | 2 | 1996 | 2227 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 503 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2015 | 599 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2013 | 324 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2013 | 291 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 407 | 0.030 |
Why?
|
| Monophenol Monooxygenase | 1 | 1991 | 69 | 0.030 |
Why?
|
| Helicobacter Infections | 1 | 2015 | 387 | 0.030 |
Why?
|
| Gestational Age | 2 | 1993 | 3493 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 2000 | 1157 | 0.020 |
Why?
|
| Respiratory System | 1 | 2015 | 557 | 0.020 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.020 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2012 | 102 | 0.020 |
Why?
|
| Myelin Proteolipid Protein | 2 | 2002 | 107 | 0.020 |
Why?
|
| Injections, Subcutaneous | 2 | 2003 | 667 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 481 | 0.020 |
Why?
|
| Nerve Degeneration | 2 | 1999 | 748 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2015 | 1101 | 0.020 |
Why?
|
| Skin Transplantation | 2 | 2011 | 1074 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2015 | 729 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 9240 | 0.020 |
Why?
|
| Cornea | 2 | 2011 | 1524 | 0.020 |
Why?
|
| Abdomen | 1 | 2017 | 1118 | 0.020 |
Why?
|
| Lymphokines | 2 | 2007 | 949 | 0.020 |
Why?
|
| Necrosis | 2 | 2010 | 1643 | 0.020 |
Why?
|
| Binding Sites | 2 | 2012 | 6111 | 0.020 |
Why?
|
| Adiposity | 1 | 2020 | 1806 | 0.020 |
Why?
|
| Interleukin-1alpha | 1 | 2011 | 85 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 375 | 0.020 |
Why?
|
| Vimentin | 2 | 1982 | 262 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2432 | 0.020 |
Why?
|
| Electroretinography | 1 | 2012 | 509 | 0.020 |
Why?
|
| Disease Progression | 3 | 2021 | 13286 | 0.020 |
Why?
|
| Restriction Mapping | 3 | 1998 | 878 | 0.020 |
Why?
|
| Triazoles | 1 | 2016 | 908 | 0.020 |
Why?
|
| Orthopedics | 1 | 2019 | 904 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 351 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 454 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 534 | 0.020 |
Why?
|
| Neutralization Tests | 2 | 1984 | 758 | 0.020 |
Why?
|
| Acetylation | 1 | 2013 | 1084 | 0.020 |
Why?
|
| Fluorophotometry | 1 | 2009 | 40 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 1997 | 345 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2011 | 212 | 0.020 |
Why?
|
| Proteinuria | 2 | 2005 | 658 | 0.020 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1990 | 156 | 0.020 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 2 | 2000 | 72 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1999 | 2441 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 1990 | 178 | 0.020 |
Why?
|
| Learning | 1 | 2019 | 1711 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 708 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3084 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2011 | 477 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1992 | 506 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 2949 | 0.020 |
Why?
|
| Antimalarials | 1 | 2016 | 905 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2009 | 92 | 0.020 |
Why?
|
| Gene Products, env | 1 | 1990 | 263 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12961 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 517 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1837 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2011 | 354 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2016 | 2715 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 2009 | 65 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2012 | 554 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 39052 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 818 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1547 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1998 | 1520 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 429 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2011 | 641 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3848 | 0.020 |
Why?
|
| Models, Biological | 1 | 1985 | 9584 | 0.020 |
Why?
|
| Aerosols | 1 | 2010 | 625 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4851 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2014 | 951 | 0.020 |
Why?
|
| Erythropoiesis | 3 | 1996 | 706 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 640 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 1970 | 0.020 |
Why?
|
| Egg Proteins | 1 | 2007 | 58 | 0.020 |
Why?
|
| Rabbits | 1 | 2014 | 4894 | 0.020 |
Why?
|
| Epithelium, Corneal | 1 | 2009 | 247 | 0.020 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1990 | 357 | 0.020 |
Why?
|
| Genotype | 4 | 2011 | 12952 | 0.020 |
Why?
|
| Time Factors | 6 | 2011 | 40075 | 0.020 |
Why?
|
| Cholesterol | 2 | 2007 | 2919 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77460 | 0.020 |
Why?
|
| Middle Aged | 5 | 2020 | 213390 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2007 | 151 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 1990 | 748 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2010 | 651 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5534 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2004 | 2216 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2012 | 1240 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 1287 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2019 | 9849 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 1172 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 677 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2013 | 1379 | 0.020 |
Why?
|
| Genes | 1 | 1990 | 1893 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2887 | 0.020 |
Why?
|
| Blood Urea Nitrogen | 1 | 2005 | 191 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2000 | 3773 | 0.020 |
Why?
|
| Indoles | 1 | 2014 | 1839 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2008 | 936 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 712 | 0.020 |
Why?
|
| Adenomatosis, Pulmonary | 1 | 2005 | 2 | 0.020 |
Why?
|
| Adenine | 1 | 1991 | 936 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 3505 | 0.020 |
Why?
|
| Adult | 5 | 2020 | 214052 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 2249 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2012 | 1340 | 0.020 |
Why?
|
| 4-1BB Ligand | 1 | 2004 | 29 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1984 | 56 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2009 | 645 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1856 | 0.020 |
Why?
|
| Integrin alpha3 | 1 | 2004 | 26 | 0.020 |
Why?
|
| Clone Cells | 3 | 1996 | 1692 | 0.020 |
Why?
|
| Zinc Fingers | 2 | 1998 | 583 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2560 | 0.020 |
Why?
|
| Oxygen | 1 | 2016 | 4189 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2014 | 1940 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57776 | 0.020 |
Why?
|
| Axons | 1 | 2012 | 1685 | 0.020 |
Why?
|
| Biopsy | 1 | 2016 | 6755 | 0.010 |
Why?
|
| Chaperonin 60 | 1 | 2004 | 103 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 2004 | 229 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 480 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 489 | 0.010 |
Why?
|
| Myocardium | 2 | 2011 | 4772 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2005 | 15297 | 0.010 |
Why?
|
| Enzyme Reactivators | 1 | 2002 | 6 | 0.010 |
Why?
|
| Biological Therapy | 1 | 2004 | 138 | 0.010 |
Why?
|
| Cell Migration Inhibition | 1 | 2002 | 96 | 0.010 |
Why?
|
| Antibodies, Helminth | 1 | 2002 | 50 | 0.010 |
Why?
|
| Haplotypes | 1 | 2009 | 2779 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 216 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1982 | 45 | 0.010 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2002 | 29 | 0.010 |
Why?
|
| Receptors, CXCR5 | 1 | 2003 | 92 | 0.010 |
Why?
|
| Parasite Egg Count | 1 | 2002 | 27 | 0.010 |
Why?
|
| IgG Deficiency | 1 | 2002 | 28 | 0.010 |
Why?
|
| Actins | 2 | 2004 | 2121 | 0.010 |
Why?
|
| Canada | 1 | 2008 | 2065 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6621 | 0.010 |
Why?
|
| Hyperplasia | 2 | 2000 | 1185 | 0.010 |
Why?
|
| Organ Transplantation | 1 | 2012 | 1140 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1984 | 623 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1990 | 1810 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3690 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1987 | 530 | 0.010 |
Why?
|
| Mutagenesis | 2 | 1996 | 1264 | 0.010 |
Why?
|
| Young Adult | 2 | 2019 | 56429 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1802 | 0.010 |
Why?
|
| Lymphocytosis | 1 | 2002 | 119 | 0.010 |
Why?
|
| Collagen | 1 | 1990 | 2688 | 0.010 |
Why?
|
| Profilins | 1 | 2001 | 66 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2003 | 422 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
| Isoantibodies | 1 | 2005 | 679 | 0.010 |
Why?
|
| Terbutaline | 1 | 2000 | 24 | 0.010 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2000 | 20 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 565 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 452 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2003 | 295 | 0.010 |
Why?
|
| Otitis Media, Suppurative | 1 | 2000 | 26 | 0.010 |
Why?
|
| Homozygote | 2 | 1999 | 1787 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 7914 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2000 | 112 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2000 | 91 | 0.010 |
Why?
|
| RecQ Helicases | 1 | 2000 | 54 | 0.010 |
Why?
|
| Methionine | 1 | 1982 | 590 | 0.010 |
Why?
|
| Ependyma | 1 | 1980 | 54 | 0.010 |
Why?
|
| Carboxypeptidases A | 1 | 1999 | 49 | 0.010 |
Why?
|
| Pedigree | 1 | 2008 | 4642 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2000 | 318 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2002 | 285 | 0.010 |
Why?
|
| Trichinella spiralis | 1 | 1999 | 28 | 0.010 |
Why?
|
| Trichinellosis | 1 | 1999 | 36 | 0.010 |
Why?
|
| Chymases | 1 | 1999 | 99 | 0.010 |
Why?
|
| Pheromones | 1 | 2000 | 97 | 0.010 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2000 | 103 | 0.010 |
Why?
|
| Aorta | 1 | 2007 | 2062 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2000 | 552 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 176 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 2000 | 113 | 0.010 |
Why?
|
| Graft vs Tumor Effect | 1 | 1999 | 72 | 0.010 |
Why?
|
| Carboxypeptidases | 1 | 1999 | 176 | 0.010 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 1999 | 61 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2009 | 15520 | 0.010 |
Why?
|
| Oxazolone | 1 | 1998 | 60 | 0.010 |
Why?
|
| Exodeoxyribonucleases | 1 | 2000 | 180 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2000 | 513 | 0.010 |
Why?
|
| Limb Buds | 1 | 1999 | 77 | 0.010 |
Why?
|
| Child | 2 | 2005 | 77709 | 0.010 |
Why?
|
| Mice, Nude | 2 | 1999 | 3689 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1989 | 2943 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1999 | 256 | 0.010 |
Why?
|
| Sulfotransferases | 1 | 1999 | 151 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3144 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40559 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 1888 | 0.010 |
Why?
|
| Amidohydrolases | 1 | 1999 | 169 | 0.010 |
Why?
|
| Complement C3 | 1 | 2000 | 461 | 0.010 |
Why?
|
| Arabinofuranosylcytosine Triphosphate | 1 | 1998 | 7 | 0.010 |
Why?
|
| Plants, Genetically Modified | 1 | 1998 | 110 | 0.010 |
Why?
|
| Tryptases | 1 | 1999 | 190 | 0.010 |
Why?
|
| Sulfates | 1 | 1999 | 390 | 0.010 |
Why?
|
| Tromethamine | 1 | 1978 | 31 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 1999 | 258 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 1085 | 0.010 |
Why?
|
| Neck | 1 | 2003 | 698 | 0.010 |
Why?
|
| Ovum | 1 | 1999 | 189 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 1999 | 236 | 0.010 |
Why?
|
| Blastocyst | 1 | 2001 | 424 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 1999 | 136 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1997 | 118 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1999 | 411 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2418 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 562 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 841 | 0.010 |
Why?
|
| Serotyping | 1 | 1978 | 338 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1999 | 798 | 0.010 |
Why?
|
| Bacterial Vaccines | 1 | 1999 | 403 | 0.010 |
Why?
|
| Jejunum | 1 | 1999 | 480 | 0.010 |
Why?
|
| Gene Library | 1 | 2000 | 1074 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2000 | 582 | 0.010 |
Why?
|
| Thioglycolates | 1 | 1996 | 39 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2000 | 1151 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2000 | 415 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1997 | 75 | 0.010 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 1996 | 45 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 1624 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 13882 | 0.010 |
Why?
|
| Opsonin Proteins | 1 | 1996 | 150 | 0.010 |
Why?
|
| Quinolones | 1 | 2000 | 367 | 0.010 |
Why?
|
| Camptothecin | 1 | 2000 | 576 | 0.010 |
Why?
|
| Chloroplasts | 1 | 1996 | 45 | 0.010 |
Why?
|
| DNA, Plant | 1 | 1996 | 50 | 0.010 |
Why?
|
| Respiratory Burst | 1 | 1996 | 114 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1997 | 230 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1996 | 82 | 0.010 |
Why?
|
| Neurons | 2 | 1990 | 9340 | 0.010 |
Why?
|
| Nervous System | 1 | 2000 | 554 | 0.010 |
Why?
|
| Acetates | 1 | 1978 | 311 | 0.010 |
Why?
|
| Craniofacial Abnormalities | 1 | 1999 | 315 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3702 | 0.010 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 1996 | 76 | 0.010 |
Why?
|
| Epidermis | 1 | 1999 | 528 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1996 | 403 | 0.010 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1996 | 174 | 0.010 |
Why?
|
| Virion | 1 | 1978 | 433 | 0.010 |
Why?
|
| Janus Kinase 3 | 1 | 1995 | 78 | 0.010 |
Why?
|
| Egg Yolk | 1 | 1995 | 24 | 0.010 |
Why?
|
| Genes, Switch | 1 | 1995 | 47 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 547 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2000 | 541 | 0.010 |
Why?
|
| Ion Channels | 1 | 2000 | 1056 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1999 | 751 | 0.010 |
Why?
|
| Fetus | 2 | 1995 | 1880 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1978 | 1801 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1997 | 460 | 0.010 |
Why?
|
| Allergens | 1 | 2002 | 1320 | 0.010 |
Why?
|
| Diet | 1 | 2013 | 7937 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 1995 | 92 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 318 | 0.010 |
Why?
|
| Prediabetic State | 1 | 2000 | 499 | 0.010 |
Why?
|
| Peritonitis | 1 | 1996 | 365 | 0.010 |
Why?
|
| Placentation | 1 | 1995 | 82 | 0.010 |
Why?
|
| Glycine | 1 | 1978 | 671 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1996 | 3461 | 0.010 |
Why?
|
| Globins | 1 | 1995 | 416 | 0.010 |
Why?
|
| Fertility | 1 | 1999 | 781 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1999 | 1842 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1997 | 707 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2000 | 748 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1980 | 1219 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 1999 | 878 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1978 | 1536 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1996 | 811 | 0.010 |
Why?
|
| Nucleotide Mapping | 1 | 1992 | 20 | 0.010 |
Why?
|
| Rhinitis | 1 | 2000 | 691 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 2000 | 1416 | 0.010 |
Why?
|
| Hemostasis | 1 | 1995 | 458 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 1995 | 504 | 0.010 |
Why?
|
| Leptin | 1 | 2000 | 1600 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20130 | 0.010 |
Why?
|
| Phylogeny | 1 | 1999 | 2804 | 0.010 |
Why?
|
| Introns | 1 | 1995 | 992 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1996 | 1252 | 0.010 |
Why?
|
| Leukocytes | 1 | 2000 | 2045 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2274 | 0.010 |
Why?
|
| Fetal Resorption | 1 | 1991 | 17 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1997 | 1420 | 0.010 |
Why?
|
| Iris | 1 | 1992 | 239 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2649 | 0.010 |
Why?
|
| Molecular Probe Techniques | 1 | 1991 | 119 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1978 | 1900 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1997 | 2634 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1995 | 1588 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1992 | 229 | 0.010 |
Why?
|
| Poly A | 1 | 1990 | 185 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 427 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 4217 | 0.010 |
Why?
|
| Procollagen | 1 | 1990 | 185 | 0.010 |
Why?
|
| Endocytosis | 2 | 1987 | 985 | 0.010 |
Why?
|
| Body Weight | 1 | 2000 | 4671 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1995 | 1608 | 0.010 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1989 | 82 | 0.010 |
Why?
|
| Mosaicism | 1 | 1991 | 441 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 476 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 15221 | 0.000 |
Why?
|
| Lactation | 1 | 1990 | 412 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 1454 | 0.000 |
Why?
|
| Hippocampus | 1 | 2000 | 3675 | 0.000 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1989 | 362 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1990 | 2646 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1990 | 982 | 0.000 |
Why?
|
| Milk, Human | 1 | 1990 | 490 | 0.000 |
Why?
|
| Anemia | 1 | 1995 | 1503 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4925 | 0.000 |
Why?
|
| Wound Healing | 1 | 1995 | 2785 | 0.000 |
Why?
|
| HIV-1 | 1 | 2000 | 6939 | 0.000 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1981 | 156 | 0.000 |
Why?
|
| Animals, Suckling | 1 | 1981 | 72 | 0.000 |
Why?
|
| Temperature | 2 | 1978 | 2204 | 0.000 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 1999 | 5445 | 0.000 |
Why?
|
| Gastrointestinal Diseases | 1 | 1990 | 1170 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1990 | 2576 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1981 | 595 | 0.000 |
Why?
|
| Genetic Code | 1 | 1978 | 154 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 1995 | 4583 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1990 | 2535 | 0.000 |
Why?
|
| Infant | 1 | 1998 | 35134 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1998 | 41005 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 4034 | 0.000 |
Why?
|
| Adolescent | 1 | 1998 | 85779 | 0.000 |
Why?
|